Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
PHASE2Active, not recruitingINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
June 28, 2022
Primary Completion Date
March 31, 2034
Study Completion Date
December 31, 2034
Conditions
Melanoma Stage IVHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaMSI-HighClear Cell Renal Cell CarcinomaNon-small Cell Lung Cancer
Interventions
BIOLOGICAL
Fecal Microbiota Transplant (FMT)
Fecal Microbiota Transplant (FMT)
Trial Locations (1)
0379
Oslo University Hospital, Oslo
All Listed Sponsors
lead
Oslo University Hospital
OTHER
NCT05286294 - Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders | Biotech Hunter | Biotech Hunter